ATR抑制剂:从向DNA损伤反应到利用合成致命性 - - 癌症治疗中的一个范式转变
Xin Zhou1, Qi Qin1, Huizhi Yao1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Road, Nanchang, Jiangxi 330013, China.
本综述详细介绍了阿塔克西亚电长iectasia和Rad3相关 (ATR) 激酶抑制剂,探讨了它们的药用化学,临床进展和挑战. 它概述了通往下一代ATR向癌症治疗的精准医学的道路.
科学领域:
- 生物化学和分子生物学
- 癌症治疗方法 癌症治疗方法
- 药用化学 医学化学
背景情况:
- ATAXIA Telangiectasia和Rad3相关的 (ATR) 激酶对于DNA复制应激反应至关重要.
- ATR激酶是DNA损伤反应 (DDR) 缺陷癌症中合成致死性的关键标.
研究的目的:
- 系统地审查ATR激酶的分子生物学.
- 分析ATR抑制剂的药物化学演变.
- 检查ATR向治疗的临床进展,挑战和未来方向.
主要方法:
- 分子生物学和药物化学文献的系统综述.
- 对临床ATR抑制剂 (贝佐索尔蒂布,塞拉拉塞尔蒂布,埃利穆塞尔蒂布) 的结构活性关系 (SAR) 的分析.
- 评估蛋白质分解向化马体 (PROTACs) 和组合疗法.
主要成果:
- 详细的SAR分析突出了改善ATR抑制剂选择性和药物可用的化学修饰.
- 确定了PROTACs的局限性以及组合疗法的挑战.
- 对剂量限制性毒性和获得性耐药机制的分析.
结论:
- ATR抑制剂看起来有前途,但面临着毒性和耐药性等挑战.
- 预测生物标志物的开发对于有效的ATR向精准医学至关重要.
- 未来的研究重点是优化ATR抑制剂和组合策略,以改善癌症治疗.
更多相关视频
04:36Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
Published on: October 17, 2025
04:07Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
